NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

I still think this comment from the NWBO press release of Feb 6, 2017 is valid. This is the most important reason to consider investing in NWBO. Nothing suggested in the past year has contradicted LL's comment. In fact, every other press release regarding the P3 study has reinforced this statement.


Dr. Linda Liau, Principal Investigator of the DCVax®-L Trial commented: “It is gratifying to have the hold removed from the Trial and exciting to see this Trial now moving towards completion, although of course the longer it takes for PFS and OS events to accrue, the better the patients in the Trial are doing.”